Meeting of the 2018 Physical Activity Guidelines Advisory Committee, 41977-41978 [2016-15206]

Download as PDF asabaliauskas on DSK3SPTVN1PROD with NOTICES Federal Register / Vol. 81, No. 124 / Tuesday, June 28, 2016 / Notices 6. Guy Sterling on behalf of A. S., Vienna, Virginia, Court of Federal Claims No: 16– 0551V 7. Derek Bailey on behalf of J. B., Odenton, Maryland, Court of Federal Claims No: 16–0552V 8. Donna Williams on behalf of C. W., Atlanta, Georgia, Court of Federal Claims No: 16–0553V 9. Nancy N. Relyea, Colonie, New York, Court of Federal Claims No: 16–0555V 10. Hope O’Bannon, Rancho Cucamonga, California, Court of Federal Claims No: 16–0556V 11. Ashley Walls on behalf of K. W., Martinsburg, West Virginia, Court of Federal Claims No: 16–0557V 12. Heather Spracklen and Joe Higgins on behalf of M. H., Stillwater, Oklahoma, Court of Federal Claims No: 16–0559V 13. Richard Deckert, St. Louis, Missouri, Court of Federal Claims No: 16–0562V 14. Kenneth Craig, Lebanon, Indiana, Court of Federal Claims No: 16–0564V 15. Hunter Horsey on behalf of G. H., Clearwater, Florida, Court of Federal Claims No: 16–0565V 16. Elaine Moriarty, Plymouth Meeting, Pennsylvania, Court of Federal Claims No: 16–0566V 17. Margaret Zamora, Cleveland, Ohio, Court of Federal Claims No: 16–0567V 18. L. Nicole Moore, Tulsa, Oklahoma, Court of Federal Claims No: 16–0569V 19. Renate Davison, Aurora, Colorado, Court of Federal Claims No: 16–0571V 20. Suzanne Niedziela, Carle Place, New York, Court of Federal Claims No: 16– 0572V 21. Paula Yost, Winchester, Virginia, Court of Federal Claims No: 16–0573V 22. Lincoln John and Daswattie John on behalf of K. J., Schenectady, New York, Court of Federal Claims No: 16–0574V 23. Shari Murray, Portland, Oregon, Court of Federal Claims No: 16–0575V 24. Susan Graney, Newport News, Virginia, Court of Federal Claims No: 16–0578V 25. Evangeline Stavretis, Fort Wayne, Indiana, Court of Federal Claims No: 16– 0579V 26. Dolores Smoot, Cleveland, Ohio, Court of Federal Claims No: 16–0580V 27. Karie N. DuVernay on behalf of W. R. D., Charlotte, North Carolina, Court of Federal Claims No: 16–0582V 28. Josh Swan, Nashua, New Hampshire, Court of Federal Claims No: 16–0583V 29. Rebecca Schleif, Baraboo, Wisconsin, Court of Federal Claims No: 16–0584V 30. Linda Bailey, Charleston, West Virginia, Court of Federal Claims No: 16–0585V 31. Nancy Tyree, White Plains, Maryland, Court of Federal Claims No: 16–0586V 32. Timothy Selling, Scottsdale, Arizona, Court of Federal Claims No: 16–0588V 33. Jeffrey Schafer, Ravenna, Ohio, Court of Federal Claims No: 16–0593V 34. Patricia Miller, Beverly Hills, California, Court of Federal Claims No: 16–0595V 35. Leah Mims and Donelle Mims on behalf of J. M., Deceased, Stone Mountain, Georgia, Court of Federal Claims No: 16– 0596V 36. Robert Rhodes, Greensboro, North Carolina, Court of Federal Claims No: VerDate Sep<11>2014 17:49 Jun 27, 2016 Jkt 238001 16–0597V 37. Teresa Polzin, Linwood, New Jersey, Court of Federal Claims No: 16–0598V 38. Eric Heagney, Asheville, North Carolina, Court of Federal Claims No: 16–0601V 39. Sheila R. Young, Oneida, New York, Court of Federal Claims No: 16–0602V 40. Jeanette Eiland, Milwaukee, Wisconsin, Court of Federal Claims No: 16–0603V 41. Aileen Harris, Phoenix, Arizona, Court of Federal Claims No: 16–0604V 42. Debora Brown, San Antonio, Texas, Court of Federal Claims No: 16–0605V 43. Michele Dominianni, New City, New York, Court of Federal Claims No: 16– 0606V 44. Catherine Cintron on behalf of E. C., Richmond, Virginia, Court of Federal Claims No: 16–0608V 45. Kathleen Nolan, North Tonawanda, New York, Court of Federal Claims No: 16– 0609V 46. John Coleman, Dallas, Texas, Court of Federal Claims No: 16–0610V 47. Russell Green, Concord, Massachusetts, Court of Federal Claims No: 16–0612V 48. Gilmore Wright, II, Buford, Georgia, Court of Federal Claims No: 16–0615V 49. David Johnson, San Antonio, Texas, Court of Federal Claims No: 16–0616V 50. Abigail Michel, Roswell, Georgia, Court of Federal Claims No: 16–0617V 51. Melissa Goyne, Dresher, Pennsylvania, Court of Federal Claims No: 16–0619V 52. Irene Schurley, Las Vegas, Nevada, Court of Federal Claims No: 16–0621V 53. Deborah Marino, Newtown, Pennsylvania, Court of Federal Claims No: 16–0622V 54. Cheryl Zanghi, Washington, District of Columbia, Court of Federal Claims No: 16–0625V 55. Leah Soos, Washington, District of Columbia, Court of Federal Claims No: 16–0626V 56. Lauren Ochoa on behalf of Scarlet Ochoa, Deceased, Seattle, Washington, Court of Federal Claims No: 16–0627V 57. Marion Crank, Jr., Beverly Hills, California, Court of Federal Claims No: 16–0628V 58. Mary Katherine Shadix, Beverly Hills, California, Court of Federal Claims No: 16–0629V 59. Diane Scott, Beverly Hills, California, Court of Federal Claims No: 16–0630V 60. Theodore Worley, Beverly Hills, California, Court of Federal Claims No: 16–0631V 61. Melissa Larson, Baraboo, Wisconsin, Court of Federal Claims No: 16–0633V 62. Wei-Ti Chen, New Haven, Connecticut, Court of Federal Claims No: 16–0634V 63. Maxine Ward, Memphis, Tennessee, Court of Federal Claims No: 16–0635V 64. Michael Miller, Washington, District of Columbia, Court of Federal Claims No: 16–0637V 65. Jake Peters, Los Angeles, California, Court of Federal Claims No: 16–0638V 66. Sharon G. Ortagus, Palatka, Florida, Court of Federal Claims No: 16–0639V 67. Sarah Graham, Washington, District of Columbia, Court of Federal Claims No: 16–0640V 68. Ronald L. Edwards, Washington, District PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 41977 of Columbia, Court of Federal Claims No: 16–0641V 69. Kellie Dovre, Farmington Hills, Michigan, Court of Federal Claims No: 16–0642V 70. Jessica Brooks, Washington, District of Columbia, Court of Federal Claims No: 16–0643V 71. Joan Hudgens, Dallas, Texas, Court of Federal Claims No: 16–0644V 72. Jennifer Jefko on behalf of K.L., Chicago, Illinois, Court of Federal Claims No: 16– 0645V 73. Marie O’Donnell, Sarasota, Florida, Court of Federal Claims No: 16–0646V [FR Doc. 2016–15207 Filed 6–27–16; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the 2018 Physical Activity Guidelines Advisory Committee Office of Disease Prevention and Health Promotion, Office of the Assistant Secretary for Health, Office of the Secretary, U.S. Department of Health and Human Services. ACTION: Notice. AGENCY: As stipulated by the Federal Advisory Committee Act (FACA), the U.S. Department of Health and Human Services (HHS) is hereby giving notice that a meeting of the 2018 Physical Activity Guidelines Advisory Committee (2018 PAGAC or Committee) will be held. This meeting will be open to the public. DATES: The meeting will be held on July 14, 2016, from 8:30 a.m. E.D.T. to 11:30 a.m. E.D.T. and on July 15, 2016, from 8:00 a.m. E.D.T. to 3:15 p.m. E.D.T. ADDRESSES: The meeting will be accessible by webcast on the Internet or by attendance in-person. For in-person participants the meeting will take place in the National Institutes of Health (NIH) John Edward Porter Neuroscience Research Center (PNRC), Building 35, Seminar Room 620. The facility is located at the NIH Main Campus at 9000 Rockville Pike, Bethesda, MD 20892. FOR FURTHER INFORMATION CONTACT: Designated Federal Officer, 2018 Physical Activity Guidelines Advisory Committee, Richard D. Olson and/or Alternate Designated Federal Officer, Katrina L. Piercy, Ph.D., R.D., Office of Disease Prevention and Health Promotion (ODPHP), Office of the Assistant Secretary for Health (OASH), HHS; 1101 Wootton Parkway, Suite LL– 100; Rockville, MD 20852; Telephone: (240) 453–8280. Additional information is available at www.health.gov/ paguidelines. SUMMARY: SUPPLEMENTARY INFORMATION: E:\FR\FM\28JNN1.SGM 28JNN1 asabaliauskas on DSK3SPTVN1PROD with NOTICES 41978 Federal Register / Vol. 81, No. 124 / Tuesday, June 28, 2016 / Notices Purpose: The inaugural Physical Activity Guidelines for Americans (PAG), issued in 2008, represents the first comprehensive guidelines on physical activity issued by the federal government. The PAG provides sciencebased advice on how physical activity can help promote health and reduce the risk of chronic disease. The PAG serves as the benchmark and primary, authoritative voice of the federal government for providing science-based guidance on physical activity, fitness, and health in the United States. Five years after the first edition of the PAG was released, ODPHP, in collaboration with the Centers for Disease Control and Prevention (CDC), the National Institutes of Health (NIH), and the President’s Council on Fitness, Sports, and Nutrition (PCFSN) led development of the PAG Midcourse Report: Strategies to Increase Physical Activity Among Youth. The second edition of the PAG will build upon the first edition and provide a foundation for federal recommendations and education for physical activity programs for Americans, including those at risk for chronic disease. The Secretary of HHS approved establishment of the 2018 PAGAC as a discretionary federal advisory committee. The Committee will provide the Department with independent, science-based advice and recommendations. The 2018 PAGAC consists of a panel of experts who are selected from the private sector. Individuals who are selected to serve on the 2018 PAGAC must have current scientific knowledge in the field of human physical activity and health promotion or the prevention of chronic disease. Appointed Committee Members: As stipulated in the charter, the 2018 PAGAC will be composed of 11–17 members. Members of the Committee are appointed by the Secretary. Information on Committee membership is available at www.health.gov/ paguidelines. Committee’s Task: The work of the 2018 PAGAC will be time-limited and solely advisory in nature. The Committee will develop recommendations based on the preponderance of current scientific and medical knowledge using a systematic review approach. The 2018 PAGAC will examine the current PAG, take into consideration new scientific evidence and current resource documents, and develop a report to the Secretary of HHS that outlines its science-based advice and recommendations for development of the PAG, second edition. The Committee will hold approximately five VerDate Sep<11>2014 17:49 Jun 27, 2016 Jkt 238001 public meetings to review and discuss recommendations. Meeting dates, times, locations, and other relevant information will be announced at least 15 days in advance of each meeting via Federal Register notice. As stipulated in the charter, the Committee will be terminated after delivery of its final report to the Secretary of HHS or two years from the date the charter was filed, whichever comes first. Purpose of the Meeting: In accordance with FACA and to promote transparency of the process, deliberations of the 2018 PAGAC will occur in a public forum. At this meeting, the 2018 PAGAC will be oriented to the PAG revision process and begin its deliberations. Meeting Agenda: The meeting agenda will include (a) review of operations for the Committee members, (b) a presentation on the history of the PAG and how they are used, (c) presentation on the literature review process, and (d) plans for future Committee work. Meeting Registration: The meeting is open to the public. The meeting will be accessible by webcast or by attendance in-person. Pre-registration is required for both web viewing and in-person attendance. To pre-register, please visit www.health.gov/paguidelines. To request a special accommodation, please email niheventapproval@mail.nih.gov. Webcast Public Participation: After pre-registration, individuals participating by webcast will receive webcast access information via email. In-Person Public Participation and Building Access: For in-person participants, the meeting will be held within the National Institutes of Health (NIH) PNRC, Building 35, as noted above in the ADDRESSES section. Details regarding registration capacity and directions will be posted on www.health.gov/paguidelines. For inperson participants, check-in at the registration desk onsite at the meeting is required and will begin at 7:30 a.m. E.D.T. each day. Please note that all visitors must enter through the NIH Gateway Center, which opens at 6:00 a.m. E.D.T. You will be asked to submit to a vehicle or personal inspection and provide a government-issued ID. Public Comments and Meeting Documents: Written comments from the public will be accepted throughout the Committee’s deliberative process; opportunities to present oral comments to the Committee will be provided at a future meeting. Written public comments can be submitted and/or viewed at www.health.gov/paguidelines using the ‘‘Submit Comments’’ and ‘‘Read Comments’’ links, respectively. Documents pertaining to Committee PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 deliberations, including meeting agendas and summaries will be available on www.health.gov/ paguidelines, and meeting materials will be available for public viewing at the meeting. Meeting information, thereafter, will continue to be accessible online and upon request at the Office of Disease Prevention and Health Promotion, OASH/HHS; 1101 Wootton Parkway, Suite LL100, Tower Building; Rockville, MD 20852; Telephone: (240) 453–8280; Fax: (240) 453–8281. Dated: June 22, 2016. Don Wright, Deputy Assistant Secretary for Health, (Office of Disease Prevention and Health Promotion). [FR Doc. 2016–15206 Filed 6–27–16; 8:45 am] BILLING CODE 4150–32–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel NIAID Investigator Initiated Program Project Applications (P01). Date: July 21, 2016. Time: 11 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 5601 Fishers Lane, Rockville, MD 20892 (Telephone Conference Call). Contact Person: James T. Snyder, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities/ Room 3G31B National Institutes of Health, NIAID, 5601 Fishers Lane MSC 9823, Rockville, MD 20892, (240) 669–5060, james.snyder@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS). E:\FR\FM\28JNN1.SGM 28JNN1

Agencies

[Federal Register Volume 81, Number 124 (Tuesday, June 28, 2016)]
[Notices]
[Pages 41977-41978]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-15206]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the 2018 Physical Activity Guidelines Advisory 
Committee

AGENCY: Office of Disease Prevention and Health Promotion, Office of 
the Assistant Secretary for Health, Office of the Secretary, U.S. 
Department of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act (FACA), 
the U.S. Department of Health and Human Services (HHS) is hereby giving 
notice that a meeting of the 2018 Physical Activity Guidelines Advisory 
Committee (2018 PAGAC or Committee) will be held. This meeting will be 
open to the public.

DATES: The meeting will be held on July 14, 2016, from 8:30 a.m. E.D.T. 
to 11:30 a.m. E.D.T. and on July 15, 2016, from 8:00 a.m. E.D.T. to 
3:15 p.m. E.D.T.

ADDRESSES: The meeting will be accessible by webcast on the Internet or 
by attendance in-person. For in-person participants the meeting will 
take place in the National Institutes of Health (NIH) John Edward 
Porter Neuroscience Research Center (PNRC), Building 35, Seminar Room 
620. The facility is located at the NIH Main Campus at 9000 Rockville 
Pike, Bethesda, MD 20892.

FOR FURTHER INFORMATION CONTACT: Designated Federal Officer, 2018 
Physical Activity Guidelines Advisory Committee, Richard D. Olson and/
or Alternate Designated Federal Officer, Katrina L. Piercy, Ph.D., 
R.D., Office of Disease Prevention and Health Promotion (ODPHP), Office 
of the Assistant Secretary for Health (OASH), HHS; 1101 Wootton 
Parkway, Suite LL-100; Rockville, MD 20852; Telephone: (240) 453-8280. 
Additional information is available at www.health.gov/paguidelines.

SUPPLEMENTARY INFORMATION: 

[[Page 41978]]

    Purpose: The inaugural Physical Activity Guidelines for Americans 
(PAG), issued in 2008, represents the first comprehensive guidelines on 
physical activity issued by the federal government. The PAG provides 
science-based advice on how physical activity can help promote health 
and reduce the risk of chronic disease. The PAG serves as the benchmark 
and primary, authoritative voice of the federal government for 
providing science-based guidance on physical activity, fitness, and 
health in the United States. Five years after the first edition of the 
PAG was released, ODPHP, in collaboration with the Centers for Disease 
Control and Prevention (CDC), the National Institutes of Health (NIH), 
and the President's Council on Fitness, Sports, and Nutrition (PCFSN) 
led development of the PAG Midcourse Report: Strategies to Increase 
Physical Activity Among Youth. The second edition of the PAG will build 
upon the first edition and provide a foundation for federal 
recommendations and education for physical activity programs for 
Americans, including those at risk for chronic disease.
    The Secretary of HHS approved establishment of the 2018 PAGAC as a 
discretionary federal advisory committee. The Committee will provide 
the Department with independent, science-based advice and 
recommendations. The 2018 PAGAC consists of a panel of experts who are 
selected from the private sector. Individuals who are selected to serve 
on the 2018 PAGAC must have current scientific knowledge in the field 
of human physical activity and health promotion or the prevention of 
chronic disease.
    Appointed Committee Members: As stipulated in the charter, the 2018 
PAGAC will be composed of 11-17 members. Members of the Committee are 
appointed by the Secretary. Information on Committee membership is 
available at www.health.gov/paguidelines.
    Committee's Task: The work of the 2018 PAGAC will be time-limited 
and solely advisory in nature. The Committee will develop 
recommendations based on the preponderance of current scientific and 
medical knowledge using a systematic review approach. The 2018 PAGAC 
will examine the current PAG, take into consideration new scientific 
evidence and current resource documents, and develop a report to the 
Secretary of HHS that outlines its science-based advice and 
recommendations for development of the PAG, second edition. The 
Committee will hold approximately five public meetings to review and 
discuss recommendations. Meeting dates, times, locations, and other 
relevant information will be announced at least 15 days in advance of 
each meeting via Federal Register notice. As stipulated in the charter, 
the Committee will be terminated after delivery of its final report to 
the Secretary of HHS or two years from the date the charter was filed, 
whichever comes first.
    Purpose of the Meeting: In accordance with FACA and to promote 
transparency of the process, deliberations of the 2018 PAGAC will occur 
in a public forum. At this meeting, the 2018 PAGAC will be oriented to 
the PAG revision process and begin its deliberations.
    Meeting Agenda: The meeting agenda will include (a) review of 
operations for the Committee members, (b) a presentation on the history 
of the PAG and how they are used, (c) presentation on the literature 
review process, and (d) plans for future Committee work.
    Meeting Registration: The meeting is open to the public. The 
meeting will be accessible by webcast or by attendance in-person. Pre-
registration is required for both web viewing and in-person attendance. 
To pre-register, please visit www.health.gov/paguidelines. To request a 
special accommodation, please email niheventapproval@mail.nih.gov.
    Webcast Public Participation: After pre-registration, individuals 
participating by webcast will receive webcast access information via 
email.
    In-Person Public Participation and Building Access: For in-person 
participants, the meeting will be held within the National Institutes 
of Health (NIH) PNRC, Building 35, as noted above in the ADDRESSES 
section. Details regarding registration capacity and directions will be 
posted on www.health.gov/paguidelines. For in-person participants, 
check-in at the registration desk onsite at the meeting is required and 
will begin at 7:30 a.m. E.D.T. each day. Please note that all visitors 
must enter through the NIH Gateway Center, which opens at 6:00 a.m. 
E.D.T. You will be asked to submit to a vehicle or personal inspection 
and provide a government-issued ID.
    Public Comments and Meeting Documents: Written comments from the 
public will be accepted throughout the Committee's deliberative 
process; opportunities to present oral comments to the Committee will 
be provided at a future meeting. Written public comments can be 
submitted and/or viewed at www.health.gov/paguidelines using the 
``Submit Comments'' and ``Read Comments'' links, respectively. 
Documents pertaining to Committee deliberations, including meeting 
agendas and summaries will be available on www.health.gov/paguidelines, 
and meeting materials will be available for public viewing at the 
meeting. Meeting information, thereafter, will continue to be 
accessible online and upon request at the Office of Disease Prevention 
and Health Promotion, OASH/HHS; 1101 Wootton Parkway, Suite LL100, 
Tower Building; Rockville, MD 20852; Telephone: (240) 453-8280; Fax: 
(240) 453-8281.

    Dated: June 22, 2016.
Don Wright,
Deputy Assistant Secretary for Health, (Office of Disease Prevention 
and Health Promotion).
[FR Doc. 2016-15206 Filed 6-27-16; 8:45 am]
 BILLING CODE 4150-32-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.